Showing 21 - 30 of 181
The general issue of balancing the value of evidence about the performance of a technology and the value of access to a technology can be seen as central to a number of policy questions. Establishing the key principles of what assessments are needed, as well as how they should be made, will...
Persistent link: https://www.econbiz.de/10010533835
There has been much speculation about a possible association between the social and built environment and health, but the empirical evidence is still elusive. The social and built environments are best seen as contextual concepts but they are usually estimated as an aggregation of individual...
Persistent link: https://www.econbiz.de/10008600793
Persistent link: https://www.econbiz.de/10004371873
Persistent link: https://www.econbiz.de/10004667568
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of dronedarone (Multaq, Sanofi-Aventis Limited, UK) to submit evidence on the clinical and cost effectiveness of the anti-arrhythmic drug (AAD) for the treatment of atrial fibrillation (AF) and atrial...
Persistent link: https://www.econbiz.de/10010614373
Background: Event based models are driven by the occurrence of clinical events such as primary clinical endpoints in randomised trials or adverse events associated with treatment. Statistical analyses of individual-patient data are used to determine event rates and further statistical analyses...
Persistent link: https://www.econbiz.de/10014049636
Persistent link: https://www.econbiz.de/10014499446
Persistent link: https://www.econbiz.de/10014499460
1. What is coaching? -- 2. Overview of solution focused coaching -- 3. Solution focused skills for coaches -- 4. More solution focused skills for coaches -- 5. The solution focused coach -- 6. Group and team coaching -- 7. Professional, ethical and practice issues -- 8. The inclusive coach -- 9....
Persistent link: https://www.econbiz.de/10014499476
Background: Missing data are potentially an extensive problem in cost-effectiveness analyses conducted alongside randomised clinical trials, where prospective collection of both resource use and health outcome information is required. There are several possible reasons for the presence of...
Persistent link: https://www.econbiz.de/10005404739